Moreover, the ongoing activation of the ERK/ELK1 pathway in ovarian cancer is discussed, particularly regarding its role in cell proliferation, and it is highlighted that inhibiting ERK1/2 can effectively curtail tumor expansion (Steinmetz et al., 2004). This evidence concerns the gene MAPK3 and neoplasm.